Alkem Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

3408.10 +110.40 ▲3.4%

31 March 2023, 04:01:00 PM
Volume: 7,192

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alkemlabs.com
Market Cap 40,626.39 Cr.
Enterprise Value(EV) 39,830.48 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 85.37 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 39.92 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 803.05 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.24 Calculated using Price: 3,408.10
Dividend Yield 1.00 Period Ending 2022-03
No. of Shares Subscribed 11.96 Cr. 119,565,000 Shares
FaceValue 2
Company Profile
The company is one of India's foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies. Steered by its industry experience of over four decades, it offers high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.35%
1 Week
+8.15%
1 Month
+7.32%
3 Month
+13.40%
6 Month
+3.91%
1 Year
-5.78%
2 Year
+22.94%
5 Year
+72.39%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.28 14.03 22.48 22.18 13.69 15.02 19.82 23.91 20.99
Return on Capital Employed (%) 14.06 13.27 23.10 21.31 17.86 16.49 18.71 22.56 18.69
Return on Assets (%) 10.14 8.16 14.59 16.61 9.91 10.66 13.92 16.66 14.50

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2,585 2,999 3,692 4,468 4,864 5,439 6,161 7,377 8,638 9,142
Non Curr. Liab. 324 201 -306 -401 -359 -289 -541 -751 -893 -843
Curr. Liab. 1,403 2,006 1,538 1,690 2,383 2,218 3,245 3,604 4,805 3,975
Minority Int. 86 95 115 122 133 148 181 209 226
Equity & Liab. 4,311 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,499
Non Curr. Assets 2,709 2,953 2,250 2,955 2,997 3,284 3,507 3,483 4,325 3,907
Curr. Assets 1,602 2,338 2,769 2,917 4,013 4,204 5,506 6,923 8,434 8,593
Misc. Exp. not W/O
Total Assets 4,311 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,499

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 3,126 3,743 4,925 5,688 6,392 7,357 8,344 8,865 10,634 11,181
Other Income 165 181 240 112 115 88 104 233 163 168
Total Income 3,291 3,924 5,165 5,800 6,507 7,445 8,449 9,098 10,797 11,348
Total Expenditure -2,716 -3,322 -4,072 -4,689 -5,383 -6,242 -6,871 -6,923 -8,581 -9,587
PBIDT 575 603 1,093 1,111 1,124 1,202 1,578 2,176 2,216 1,761
Interest -93 -81 -71 -45 -55 -55 -65 -59 -52 -95
Depreciation -52 -71 -93 -101 -143 -193 -253 -275 -304 -315
Taxation 5 -59 -176 -60 -288 -181 -110 -224 -164 -288
Exceptional Items -15 -15
PAT 435 392 752 905 638 774 1,149 1,618 1,680 1,047
Minority Interest -11 -13 -7 -13 -22 -33 -35 -27
Share Associate
Other Related Items
Consolidated Net Profit 435 392 742 892 631 761 1,127 1,585 1,646 1,021
Adjusted EPS 36 33 62 75 53 64 94 133 138 85

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 78 290 325 726 471 266 780 585 1,265 1,111
Cash Fr. Inv. -404 350 -237 202 -286 -357 -316 -741 -999 -1,435
Cash Fr. Finan. 356 -600 -52 -927 -138 85 -379 79 -272 380
Net Change 30 41 37 1 47 -7 84 -77 -5 55
Cash & Cash Eqvt 57 101 140 127 167 167 249 176 174 232

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 62.43 60.16 58.84 58.84 57.13 57.13 57.14 57.16 57.16
Public 37.57 39.84 41.16 41.16 42.87 42.87 42.86 42.84 42.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 27 Mar 2023
Closure of Trading Window
This is to inform you that in terms of Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window will remain closed from 30th March 2023 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March 2023 are communicated to the Stock Exchanges.
Mon, 27 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted.
Thu, 23 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 attached herewith are the details of Analyst/ Institutional Investor meetings to be conducted.

Technical Scans View Details >>

Fri, 31 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Alkem Laboratories Ltd.

What is Alkem Laboratories share price?
Can I buy Alkem Laboratories shares now?
What is the Dividend Yield of Alkem Laboratories?
What is the Market Cap of Alkem Laboratories?
What are the key metrics to analyse Alkem Laboratories?
What is the 52 Week High and Low of Alkem Laboratories?
What is the trend of Alkem Laboratories share price?